Shortly after making an M&A play to break into the CDMO business, Granules’ manufacturing bona fides have come under fire in a newly published rebuke by the U.S. FDA. In a warning letter dated ...

Granules India Ltd share price was down by -0.17% from the previous closing price of ₹494.00. Who are peers of Granules India Ltd? The peers of Granules India Ltd are Sun Pharmaceuticals ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Mycetoma is a chronic, subcutaneous infection that causes local tissue destruction, leading to deformity, disability, and social stigma. Safe and effective treatments for mycetoma are urgently needed; ...

Shares of Granules India Ltd. fell as much as 3% on Wednesday, March 5, after the United States Food and Drug Administration (USFDA) made the warning letter issued to the company's Gagillapur unit ...

Aditya Birla SL Pure Value Fund (G) 117.60 25,46,492 2.22 Aditya Birla SL Pure Value Fund (IDCW) 117.60 25,46,492 2.22 Aditya Birla SL Pure Value Fund - Direct (G ...

Shares of Granules India Ltd. climbed nearly 3% on monday hitting an intraday high of ₹474.74, after Life Insurance Corporation of India (LIC) increased its stake in the pharmaceutical company to 5.02 ...

Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 11,542.70 Crore) operating in Pharmaceuticals sector. Granules India Ltd. key Products/Revenue ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Seven stocks, including Aarti Industries and Adani Enterprises, faced trading restrictions on Monday as their open interest exceeded market limits. Despite a previous day decline, Indian equity ...